Physician profile
Ann Mccune
NPI 1184939944
$340.28
in general payments reported to CMS, 2019-2025
10 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.80 · 2022: $83.75 · 2023: $43.44 · 2024: $37.60 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $212.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $147.30 | 2022-2025 | Durolane, Gelsyn-3 |
| Novo Nordisk INC | $43.23 | 2021-2022 | |
| Lilly USA, LLC | $27.08 | 2021-2022 | |
| Exact Sciences Corporation | $24.99 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $19.00 | 2025 | |
| Alcon Vision LLC | $18.45 | 2023 | Total30 |
| Janssen Pharmaceuticals, INC | $16.42 | 2021 | |
| Abbvie INC. | $15.38 | 2025 | |
| Glaxosmithkline, LLC. | $14.32 | 2022 | |
| Amgen INC. | $14.11 | 2024 | Otezla, Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Mccune listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.